An NIH Director's Wednesday Afternoon Lecture Series Event
Marfan Syndrome and Releated Disorders: from Molecules to Medicines
Speaker: Harry Dietz, MD
Victor A. McKusick Professor of Medicine and Genetics
Institute of Genetic Medicine
Departments of Pediatrics, Medicine, Molecular Biology
and Genetics, and Neurosurgery
Johns Hopkins University School of Medicine
Investigator, Howard Hughes Medical Institute
Wednesday, January 14, 2009
National Institutes of Health
For more information and accommodations, call Christopher Wanjek at 301-402-4274.
Visit the Wednesday Afternoon Lecture Series Web site at http://www1.od.nih.gov/wals/.
The Astute Clinician Lecture Series
The Astute Clinician Lecture was established through a gift from the late Dr. Robert W. Miller and his wife, Haruko. It honors a US scientist who has observed an unusual clinical occurrence, and by investigating it, has opened an important new avenue of research.
Continuing Medical Education (CME) activities offered by NIH are jointly sponsored in partnership with The Johns Hopkins University School of Medicine Office of CME.
The WALS is intended for advanced students and practitioners in biomedical fields, healthcare professionals, and doctoral-level scientists who seek to update and broaden their understanding of contemporary biomedical research and the environment in which it is conducted.
Activity Description: The Wednesday Afternoon Lecture Series provides a mechanism to stay abreast of state-of-the-art biomedical and health research.
Intended Audience: All physicians, allied health professionals and non-clinical scientists, as well as the general public, are invited to attend the Wednesday Afternoon Lecture Series.
Objectives: After attending the activity, participants will be able to: (1) define options, alternatives, and new practices that will guide the conduct of research; (2) evaluate practical information presented about laboratory, clinical, and population-based research principles based on state-of-the-art scientific discovery and achievements; and (3) analyze information and opportunities to increase and improve collaboration among investigators and move scientific frontiers forward.
Accreditation Statement: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The Johns Hopkins University School of Medicine and the National Institutes of Health. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement: The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 45 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Policy on Speaker and Provider Disclosure: It is the policy of The Johns Hopkins University School of Medicine that the speaker and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). The Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the activity handout materials.
Past Astute Clinician Lectures
"From the Rivers of Babylon to the Coronary Blood Stream"
Wednesday, November 7, 2007 - Dr. Barry S. Coller, M.D.
"Listening to Patients: Lessons Learned in the Development of Cancer Immunotherapy"
Wednesday, November 1, 2006 - Dr. Steven A. Rosenberg, M.D.
"Inflammation, CRP and Cardiovascular Risk: Is It Time to Change the
Framingham Risk Score?"
Wednesday, November 2, 2005 - Dr. Paul M. Ridker, M.D.
Resistance and Metabolic Syndromes: Different Names, Different
Concepts, Different Goals"
Wednesday, November 3, 2004 - Dr. Gerald M. Reaven, M.D.
Implants, Past, Present, and Future,"
Wednesday, November 5, 2003 - Richard T. Myamoto, M.D.
A Window on Infectious Diseases,"
Wednesday, November 06, 2002 - Henry Masur, M.D.,
Chief, Critical Care Medicine Department, NIH
A Tyrosine Kinase Inhibitor for the Treatment of Chronic Myelogenous
Leukemia (CML) Validating the Promise of Molecularly Targeted
Wednesday, November 07, 2001 - Brian Druker, M.D.
Patients Who Taught Me and Led to My Discoveries in Congenital
Dec. 13, 2000 - Maria I. New, M.D.
NOTE: PDF documents require the free